1. Home
  2. RDHL vs MITQ Comparison

RDHL vs MITQ Comparison

Compare RDHL & MITQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RDHL
  • MITQ
  • Stock Information
  • Founded
  • RDHL 2009
  • MITQ N/A
  • Country
  • RDHL Israel
  • MITQ United States
  • Employees
  • RDHL N/A
  • MITQ N/A
  • Industry
  • RDHL Biotechnology: Pharmaceutical Preparations
  • MITQ Telecommunications Equipment
  • Sector
  • RDHL Health Care
  • MITQ Telecommunications
  • Exchange
  • RDHL Nasdaq
  • MITQ Nasdaq
  • Market Cap
  • RDHL 7.5M
  • MITQ 6.6M
  • IPO Year
  • RDHL N/A
  • MITQ 2021
  • Fundamental
  • Price
  • RDHL $5.64
  • MITQ $0.93
  • Analyst Decision
  • RDHL
  • MITQ
  • Analyst Count
  • RDHL 0
  • MITQ 0
  • Target Price
  • RDHL N/A
  • MITQ N/A
  • AVG Volume (30 Days)
  • RDHL 13.8K
  • MITQ 4.5M
  • Earning Date
  • RDHL 08-29-2024
  • MITQ 02-12-2025
  • Dividend Yield
  • RDHL N/A
  • MITQ N/A
  • EPS Growth
  • RDHL N/A
  • MITQ N/A
  • EPS
  • RDHL N/A
  • MITQ N/A
  • Revenue
  • RDHL $3,707,000.00
  • MITQ $18,756,000.00
  • Revenue This Year
  • RDHL $224.90
  • MITQ N/A
  • Revenue Next Year
  • RDHL $82.69
  • MITQ N/A
  • P/E Ratio
  • RDHL N/A
  • MITQ N/A
  • Revenue Growth
  • RDHL N/A
  • MITQ N/A
  • 52 Week Low
  • RDHL $5.41
  • MITQ $0.42
  • 52 Week High
  • RDHL $31.50
  • MITQ $1.55
  • Technical
  • Relative Strength Index (RSI)
  • RDHL 35.38
  • MITQ 69.55
  • Support Level
  • RDHL $5.41
  • MITQ $0.68
  • Resistance Level
  • RDHL $5.79
  • MITQ $1.55
  • Average True Range (ATR)
  • RDHL 0.31
  • MITQ 0.15
  • MACD
  • RDHL -0.05
  • MITQ 0.02
  • Stochastic Oscillator
  • RDHL 14.26
  • MITQ 33.83

About RDHL Redhill Biopharma Ltd.

Redhill Biopharma Ltd is a specialty biopharmaceutical company focused on gastrointestinal diseases. The company is focused primarily on the advancement of its development pipeline of clinical-stage therapeutic candidates. The company also commercializes in the U.S. GI-related products, Talicia (omeprazole, amoxicillin, and rifabutin) and Aemcolo (rifamycin). The company's current pipeline consists of five therapeutic candidates, which are Opaganib, RHB-107, RHB-102, RHB-204, and RHB-104, most of which are in clinical development.

About MITQ Moving iMage Technologies Inc.

Moving iMage Technologies Inc is engaged in providing designed equipment as well as other off the shelf cinema products needed for contemporary cinema requirements. It offers technical, design and consulting services such as custom engineering, systems design, integration and installation and digital technology, as well as software solutions for operations enhancement and theatre management.

Share on Social Networks: